Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocon LtdfiledCriticalBiocon Ltd
Priority to MYPI2018002662ApriorityCriticalpatent/MY195395A/en
Publication of MY195395ApublicationCriticalpatent/MY195395A/en
The present invention relates generally to the field of generating recombinant chimeric fusion proteins to be used in the cancer therapy, and more specifically, to fusion molecules of Anti-EGFR1-TGF?RII, Anti-EGFR1-PD1 and Anti-CTLA4-PD1 and methods of generating same, wherein the methods reduce production costs and increase homogeneity of the recombinant chimeric fusion proteins.
MYPI2018002662A2014-03-102014-03-10Fusion Immunomodulatory Proteins and Methods for Making Same
MY195395A
(en)